溴莫尼定 T20157
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
500 mg | 59803-98-4 | ¥7,880.00 | 询底价 |
1 mg | 59803-98-4 | ¥159.00 | 询底价 |
10 mg | 59803-98-4 | ¥595.00 | 询底价 |
5 mg | 59803-98-4 | ¥335.00 | 询底价 |
100 mg | 59803-98-4 | ¥3,570.00 | 询底价 |
25 mg | 59803-98-4 | ¥1,290.00 | 询底价 |
50 mg | 59803-98-4 | ¥2,390.00 | 询底价 |
1 mL | 59803-98-4 | ¥372.00 | 询底价 |
Product Introduction
Bioactivity
英文名: Brimonidine
描述: Brimonidine (Bromoxidine) 是一种完全的α2肾上腺素受体激动剂。
体外活性: [3H]Brimonidine is a full agonist at alpha 2-adrenergic receptors labeling at least 2 specific binding sites in the human brain that both have the characteristics of an alpha 2-adrenergic binding site. GTP decreases agonist binding at both of these sites, but with different potencies at each site [1].
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 26 mg/mL (89.0 mM)
关键字: Beta Receptor | Adrenergic Receptor | UK14304 | Brimonidine | inhibit | UK 14304 | Inhibitor | UK-14304
相关产品: Ifenprodil | Landiolol hydrochloride | Trazodone hydrochloride | Indanidine | Tamsolusin Hydrochloride | (S)-(-)-Propranolol hydrochloride | 2-Methoxyidazoxan monohydrochloride | Bevantolol hydrochloride | Quetiapine hemifumarate | Naphazoline
相关库: FDA-Approved Drug Library | Anti-Neurodegenerative Disease Compound Library | Drug Repurposing Compound Library | Anti-Cancer Drug Library | Membrane Protein-targeted Compound Library | Bioactive Compounds Library Max | Anti-Cancer Clinical Compound Library | GPCR Compound Library | Anti-Cancer Approved Drug Library | EMA Approved Drug Library
溴莫尼定 T20157信息由TargetMol中国为您提供,如您想了解更多关于溴莫尼定 T20157报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途